Activation of Nrf2 Pathways Correlates With Resistance of NSCLC Cell Lines to CBP501 in Vitro

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-13-0808
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Multiple Pathways of Apoptosis Induced by Roscovitine in Leukemic Cell Lines in Vitro

The Open Pharmacology Journal
2008English

Rimonabant-Induced Apoptosis in Leukemia Cell Lines: Activation of Caspase-Dependent and -Independent Pathways

Biochemical Pharmacology
BiochemistryPharmacology
2010English

Overexpression of PAD4 Suppresses Drug Resistance of NSCLC Cell Lines to Gefitinib Through Inhibiting Elk1-Mediated Epithelial-Mesenchymal Transition

Oncology Reports
MedicineCancer ResearchOncology
2016English

Trastuzumab Emtansine Delays and Overcomes Resistance to the Third-Generation EGFR-TKI Osimertinib in NSCLC EGFR Mutated Cell Lines

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2017English

Multiple Signaling Pathways Must Be Targeted to Overcome Drug Resistance in Cell Lines Derived From Melanoma Metastases

Molecular Cancer Therapeutics
Cancer ResearchOncology
2006English

NRF2 Drives Serine/Glycine Biosynthesis to Promote NSCLC Tumorigenesis

Cancer Discovery
Oncology
2015English

Activation of the Nrf2 Response by Intrinsic Hepatotoxic Drugs Correlates With Suppression of NF-κB Activation and Sensitizes Toward TNFα-induced Cytotoxicity

Archives of Toxicology
MutagenesisToxicologyHealthMedicine
2015English

NRF2 Activation in Cancer: From DNA to Protein

Cancer Research
Cancer ResearchOncology
2019English

Resistance to Telomerase Inhibition by Human Squamous Cell Carcinoma Cell Lines

International Journal of Oncology
Cancer ResearchOncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy